Back to search
FDAFDA · Food and drugs·Recall number D-0122-2018

LaBri's Body Health XPLODE 30 capsules Exclusively distribute worldwide by LaBri's Body Health.

Published December 27, 2017 · Recall initiated: July 24, 2017

Summary

FDA records drug Class I recall D-0122-2018, published December 27, 2017 and initiated July 24, 2017. Recalling firm: EZWeightLossTX LLC; Status: Terminated; Reported quantity: 1424 bottles; Lot: All lots remaining within expiry. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without An Approved NDA/ANDA: Tainted Product Marketed As a Dietary Supplements: products found to be tainted with sibutramine making these unapproved drugs.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
EZWeightLossTX LLC
Distributor
Nationwide
Lot
All lots remaining within expiry.
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was LaBri's Body Health XPLODE 30 capsules Exclusively distribute worldwide by LaBri's Body Health. recalled?

Yes. FDA published recall D-0122-2018 on December 27, 2017. Reported hazard: Marketed Without An Approved NDA/ANDA: Tainted Product Marketed As a Dietary Supplements: products found to be tainted with sibutramine making these unapproved drugs.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release